COR insider Mauch exercises 3,225 options and sells 4,968 shares under 10b5-1 plan
Rhea-AI Filing Summary
Robert P. Mauch, President & CEO and Director of Cencora, Inc. (COR), reported option exercises and open-market sales on 08/18/2025. He exercised 3,225 non-qualified stock options with an exercise price of $86.09 under a grant that vests in four prior annual installments, and those options produced 3,225 shares recorded as acquired. The same day he sold 4,968 shares at $293.53 per share pursuant to a Rule 10b5-1 trading plan adopted 11/15/2024. After these transactions he beneficially owned 40,608 shares and held 22,577 derivative securities (options) reported as direct ownership.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, which provides an affirmative defense and reduces regulatory ambiguity
- Exercise price of $86.09 vs sale price $293.53 indicates a favorable spread for the reporting person, demonstrating value creation from prior grants
- Filing discloses post-transaction holdings (40,608 shares and 22,577 options), improving transparency for investors
Negative
- Insider sale of 4,968 shares could be viewed negatively by some investors, though it was performed under a pre-established plan
- Form does not state the economic proceeds or the percentage of total outstanding shares represented, limiting assessment of market impact
Insights
TL;DR: CEO exercised vested options then sold a portion of shares via a pre-established 10b5-1 plan; transactions appear routine and pre-planned.
The filing shows a standard exercise of vested non-qualified options and contemporaneous sales executed under a Rule 10b5-1 plan adopted on 11/15/2024, which provides the reporter an affirmative defense against insider trading claims. The exercise price ($86.09) is substantially below the sale price ($293.53), indicating a cash-positive outcome for the reporting person but the Form 4 does not state the proceeds or purpose of the sale. Holdings after the transactions are disclosed, improving transparency on insider position.
TL;DR: Compensation-related option exercise followed by sales under a 10b5-1 plan; typical liquidity event for vested equity.
The derivative detail confirms the exercised options were part of a multi-year vesting schedule with prior vesting dates listed. The report clarifies that the sale occurred under an established trading plan, reducing legal/regulatory risk. There is no indication in this filing of unplanned or opportunistic insider activity; however, materiality to shareholders depends on the size of holdings relative to outstanding shares, which is not provided here.
FAQ
What did Robert P. Mauch report on Form 4 for Cencora (COR)?
Were the share sales executed under a trading plan for COR insider Robert P. Mauch?
How many shares and options did Mauch own after the transactions?
What is the exercise schedule referenced in the Form 4?
Does the Form 4 indicate any amendment or legal concerns?